85
Participants
Start Date
November 14, 2016
Primary Completion Date
July 4, 2023
Study Completion Date
July 4, 2023
HYQVIA
Participants received HYQVIA/HyQvia SC which contains both Immune Globulin Infusion 10% (Human) (IGI, 10%) and recombinant human hyaluronidase (rHuPH20).
Hosp.Britanico de Buenos Aires, Ciudad Autonoma Buenos Aires
Århus Universitetshospital, Aarhus C
Clinical Center of Serbia, Belgrade
Military Medical Academy, Belgrade
Instituto Nacional de Ciencias Médicas y Nutricion Dr. Salvador Zubiran, Mexico City
Azienda Ospedaliero Universitaria San Martino, Genova
Clinical Center Nis, Niš
Pamukkale Uni. Med. Fac., Denizli
University Hospital of Patra, Pátrai
Fondazione Istituto Neurologico Casimiro Mondino, Pavia
Groupe Hospitalier Pellegrin - Hôpital Pellegrin, Bordeaux
Azienda Ospedaliero-Universitaria Santa Maria della Misericordia, Udine
Dokuz Eylul University Faculty of Medicine, Izmir
Selcuk Universitesi Selcuklu Tip Fakultesi Hastanesi, Konya
Celal Bayar University Medical Faculty, Manisa
Azienda Ospedaliero Universitaria Pisana, Pisa
Hopital Neurologique Pierre Wertheimer, Bron
Arizona Neuromuscular Research Center, Phoenix
Fakultna nemocnica Nitra, Nitra
Azienda Ospedaliera Universitaria Policlinico G. Martino, Messina
Instituto de Neurologia de Curitiba - Hospital Ecoville, Curitiba
University of Alberta Hospital, Edmonton
LHSC - University Hospital, London
Toronto General Hospital, University Health Network, Toronto
"Institucion Prestadora de Servicios de Salud de la Universidad de Antioquia IPS UNIVERSITARIA", Medellín
Fakultni nemocnice Ostrava, Ostrava
Fakultni nemocnice v Motole, Prague
CHU de Nice, Nice
Universitaetsklinikum Leipzig AoeR, Leipzig
Uniwersyteckie Centrum Kliniczne, Gdansk
Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego, Lodz
Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie, Lublin
Hospital Universitari Vall d'Hebron, Barcelona
King's College Hospital, London
The Walton Centre, Liverpool
Takeda Development Center Americas, Inc.
INDUSTRY
Baxalta now part of Shire
INDUSTRY